YonaLink provides an EHR-to-EDC integration SaaS that exports up-to-date patient data from clinical sites’ EHRs and populates clinical research electronic data capture systems in real time. Its next-generation EDC combines EDC and eSource functionality and includes built-in eConsent and ePRO/eCOA to streamline trial data capture and validation. The platform is designed to be set up quickly, eliminate integration delays, reduce costs, and accelerate study timelines. YonaLink is headquartered in Boston with R&D operations in Israel and aims to bring its technology to the US, Europe, and Israel. The company plans to expand platform capabilities and drive adoption among clinical trial sponsors and CRO partners. Financially, YonaLink has completed an initial $6 million funding round to scale global growth and hire additional talent.

Total raised

$6M

Funding rounds

1

Latest round

Equity

Latest activity

Nov 2022